Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...
DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation
Denali obtains Breakthrough Therapy Designation for its experimental candidate, tividenofusp alfa (DNL310), for the treatment of pateints with Hunter syndrome.
The Austin Chronicle1d
Follies, Samurai, and a Few Non-Alcoholic Events for the Weekend
Got a resolution to get out more? No problem.
Denali Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II)
Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tividenofusp alfa (DNL310) for the treatment ...
Denali Therapeutics announces U.S. FDA BTD granted for tividenofusp
Denali Therapeutics (DNLI) announced that the U.S. Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for ...
Do you have HMPV? The symptoms to check for as the Chinese virus spreads
With cases of HMPV surging in China, people are fearing a Covid-like pandemic hitting the UK – but how worried should we be?
21-year-old fed up with Australia’s broken medical system
A young woman with polycystic ovary syndrome has shared the huge flaws in Australia’s medical system after paying to “introduce herself” to a gynaecologist.